StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — Aditya Agarwal, Coheron Brokers

BUYTorrent Pharmaceuticals Limited
Torrent Pharmaceuticals share price target & all analyst calls

byAditya Agarwal, Coheron BrokersHorizon: NA (inferred Swing (≤2wk))21 Jul 2026via Business Today

Entry₹5,040.7Inferred
Target₹5,200
Total upside +3.16% (call closed)
Stop loss₹4,920-2.39% risk
Exit₹4,92028 Jul 2026, 10:00 am
Stop-loss hit-2.39%
Follow Aditya Agarwal for new calls(30% target hit, 23 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 1 active Swing call on TORNTPHARMSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Jul 2026
2 supporting1 neutral2 opposing
Supports the BUY call (2)

The company has received final listing and trading approval for equity shares issued and allotted under a Scheme of Amalgamation.

BSE · Company Update·27 Jul · today

(opens in new tab)

Torrent Pharmaceuticals Ltd has received a certified copy of the final order from NCLT sanctioning the amalgamation scheme of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals.

BSE · Company Update·7 Jul · 3w ago

(opens in new tab)
Neutral / worth noting (1)

Torrent Pharmaceuticals Ltd has set a record date for the amalgamation scheme with J.B. Chemicals & Pharmaceuticals Ltd.

BSE · Corp. Action·7 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (2)

Torrent Pharma is voluntarily recalling select batches of Semalix injection disposable pens due to a product recall notification from its manufacturer, Dr. Reddy's Laboratories, for technical evaluati

NSE · Press Release·9 Jul · 3w ago

(opens in new tab)

Torrent Pharma is voluntarily recalling select batches of Semalix injection disposable pens due to a product recall notification from its manufacturer, Dr. Reddy's Laboratories, for technical evaluati

BSE · Company Update·9 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Torrent Pharmaceuticals

All analyst calls on Torrent Pharmaceuticals

More from Aditya Agarwal, Coheron Brokers

Every call and its outcome